References
- Banky B, Raso-Barnett L, Barbai T, et al (2012). Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression. Mol Cancer, 11, 83. https://doi.org/10.1186/1476-4598-11-83
- Branca M, Giorgi C, Santini D, et al (2006). Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol, 59, 40-7. https://doi.org/10.1136/jcp.2005.026922
- Duan L, Ye L, Zhao G, et al (2012). Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg.
- Fox S B, Gatter K C, Jackson D G, et al (1993). CD44 and cancer screening. Lancet, 342, 548-9. https://doi.org/10.1016/0140-6736(93)91670-H
- Gotley D C, Fawcett J, Walsh M D, et al (1996). Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer, 74, 342-51. https://doi.org/10.1038/bjc.1996.364
- Gombos Z, Xu X, Chu CS, et al (2005). Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res, 11, 8364-71. https://doi.org/10.1158/1078-0432.CCR-05-1238
- Hashimoto I, Kodama J, Seki N, et al (2001). Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer, 85, 93-7. https://doi.org/10.1054/bjoc.2001.1846
- Inoue A, Moriya H, Katada N, et al (2008). Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int, 58, 611-9. https://doi.org/10.1111/j.1440-1827.2008.02279.x
- Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300 https://doi.org/10.3322/caac.20073
- K L Bennett, D G Jackson, J C Simon, et al (1995). D44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol, 128, 687-98. https://doi.org/10.1083/jcb.128.4.687
- Kunlabut K, Vaeteewoottacharn K, Wongkham C, et al (2012). Aberrant expression of cd44 in bile duct cancer correlates with poor prognosis. Asian Pac J Cancer Prev, 13, 95-9.
- Liu L, Ma X-L, Xiao ZL, et al (2012). Prognostic value of vascular endothlial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev, 13, 3089-97. https://doi.org/10.7314/APJCP.2012.13.7.3089
- Li Yuan, Liu Jinzhong, Zheng Yanli, et al (2009). Expressions of CD44v3 and CD54 in oral premalignant epithelia. J Pract Stomatol, 25, 694-7.
- Mathur SP, Mathur RS, Gray EA, et al (2005). Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A. Gynecol Oncol, 98, 467-83. https://doi.org/10.1016/j.ygyno.2005.05.003
- Naor D, Wallach-Dayan SB, Zahalka MA, et al (2008). Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol, 18, 260-7. https://doi.org/10.1016/j.semcancer.2008.03.015
- Roye GD, Myers RB, Brown D, et al. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer, 69, 254-8.
- SpeiserP, Wanner C, Tempfer C, et al (1997). CD44 is an independent prognostic factor in early-stage cervical cancer. Int J Cancer, 74, 185-8. https://doi.org/10.1002/(SICI)1097-0215(19970422)74:2<185::AID-IJC8>3.0.CO;2-V
- Su JL,Yen CJ, Chen PS, et al (2007). The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer, 96, 541-5. https://doi.org/10.1038/sj.bjc.6603487
- Schlessinger J, Lax I, Lemmon M (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell, 83, 357-60. https://doi.org/10.1016/0092-8674(95)90112-4
- Tavassoli FA, Devilee P, et al (2003). World health organization classification of tumors. pathology and genetics of tumours of the breast and female genital organs. IARC Press: Lyon.
- Tawfik OW, Kramer B, Shideler B, et al (2007). Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma. Arch Pathol Lab Med, 131, 261-7.
- van der Voort R, Taher T E, Wielenga V J, et al (1999). Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem, 274, 6499-506. https://doi.org/10.1074/jbc.274.10.6499
- Wang SJ, Wreesmann VB, Bourguignon LY (2007). Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neckcancer. Head Neck, 29, 550-8. https://doi.org/10.1002/hed.20544
- Xie LX, Zhai TT, Yang LP, et al (2013). Lymphangiog enesis and prognostic significance of vascular endothelial growth factor c in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol, 94, 39-46. https://doi.org/10.1111/iep.12005
- Zhongliang Wang, Yao Chen, Xiaofeng Li, et al (2012). Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis. Asian Pac J Cancer Prev, 13, 27-31. https://doi.org/10.7314/APJCP.2012.13.1.027
Cited by
- Expression of Vimentin and Ki-67 Proteins in Cervical Squamous Cell Carcinoma and their Relationships with Clinicopathological Features vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4271
- Remodeling of angiogenesis and lymphangiogenesis in cervical cancer development vol.10, pp.3, 2016, https://doi.org/10.1134/S1990750816030094